Literature DB >> 7633128

Effective treatment of liver metastases from colon cancer with a combination of gamma-interferon and cisplatin chemotherapy: report of a case.

N Kohara1, F Kitaoka, K Komuta, M Yamamoto, K Motojima, T Kanematsu.   

Abstract

We report herein the case of a 63-year-old man with cancer of the sigmoid colon and metastatic nodules in the liver who was effectively treated with a combination of cisplatin regional chemotherapy, given through the hepatic artery, in conjunction with a 3-week course of intravenous gamma-interferon (INF-gamma), following palliative sigmoidectomy and dissection of the regional lymph nodes. This was followed-up by a 3-month course of oral 5-fluorouracil. Hepatic imaging performed 6 months postoperatively showed no masses in the right hepatic lobe and an apparent decrease in the size of the tumor in the left lobe. A second-look operation with resection performed at this time confirmed the efficacy of the chemotherapy. The patient survived in excess of 30 months following his initial surgery before succumbing to hepatic failure.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7633128     DOI: 10.1007/bf00311260

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  13 in total

1.  Interferon alpha-2a and 5-fluorouracil for advanced colorectal carcinoma. Assessment of activity and toxicity.

Authors:  N Kemeny; A Younes; K Seiter; D Kelsen; P Sammarco; L Adams; S Derby; P Murray; C Houston
Journal:  Cancer       Date:  1990-12-15       Impact factor: 6.860

2.  Fluorouracil and recombinant alfa-2a-interferon: an active regimen against advanced colorectal carcinoma.

Authors:  S Wadler; E L Schwartz; M Goldman; A Lyver; M Rader; M Zimmerman; L Itri; V Weinberg; P H Wiernik
Journal:  J Clin Oncol       Date:  1989-12       Impact factor: 44.544

Review 3.  Antineoplastic activity of the combination of interferon and cytotoxic agents against experimental and human malignancies: a review.

Authors:  S Wadler; E L Schwartz
Journal:  Cancer Res       Date:  1990-06-15       Impact factor: 12.701

4.  Colorectal carcinoma in vitro is more sensitive to 1-hexylcarbamoyl-5-fluorouracil compared with six other antitumor drugs: carboquone, Adriamycin, mitomycin C, aclacinomycin A, cisplatin, 5-fluorouracil.

Authors:  Y Maehara; H Anai; H Kusumoto; T Kusumoto; K Sugimachi
Journal:  Dis Colon Rectum       Date:  1988-01       Impact factor: 4.585

5.  Prolonged and continuous percutaneous intra-arterial hepatic infusion chemotherapy in advanced metastatic liver adenocarcinoma from colorectal primary.

Authors:  R A Oberfield; J A McCaffrey; J Polio; M E Clouse; T Hamilton
Journal:  Cancer       Date:  1979-08       Impact factor: 6.860

6.  Mechanisms of combined effects of gamma-interferon and 5-fluorouracil on human colon cancers implanted into nude mice.

Authors:  K Morikawa; D Fan; Y M Denkins; B Levin; J U Gutterman; S M Walker; I J Fidler
Journal:  Cancer Res       Date:  1989-02-15       Impact factor: 12.701

7.  Phase I and II studies of the combination of recombinant human interferon-gamma and 5-fluorouracil in patients with advanced colorectal carcinoma.

Authors:  J A Ajani; A A Rios; K Ende; J L Abbruzzese; C Edwards; J S Faintuch; S Saks; J U Gutterman; B Levin
Journal:  J Biol Response Mod       Date:  1989-04

8.  Modulation of 5-fluorouracil-induced toxicity in mice with interferon or with the interferon inducer, polyinosinic-polycytidylic acid.

Authors:  R L Stolfi; D S Martin; R C Sawyer; S Spiegelman
Journal:  Cancer Res       Date:  1983-02       Impact factor: 12.701

9.  Hepatic resection for colorectal liver metastases. Influence on survival of preoperative factors and surgery for recurrences in 80 patients.

Authors:  B Nordlinger; M A Quilichini; R Parc; L Hannoun; E Delva; C Huguet
Journal:  Ann Surg       Date:  1987-03       Impact factor: 12.969

Review 10.  5-Fluorouracil and recombinant interferon alfa-2a: review of activity and toxicity in advanced colorectal carcinomas.

Authors:  R Pazdur; D Jackson; B Shepherd; D Saddler; L Font; M McCardell; P Myers; S Schmidt
Journal:  Oncol Nurs Forum       Date:  1991 Jan-Feb       Impact factor: 2.172

View more
  1 in total

1.  Reduction of tumorigenicity by an interferon-gamma-gene-transduced tumor on another syngeneic tumor in a murine model.

Authors:  Y Ichinose; T Okino; S Yamasaki; Y Moriguchi; T Sugie; L Li; S Kanaoka; N Kan; Y Watanabe; M Imamura
Journal:  Surg Today       Date:  1999       Impact factor: 2.549

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.